Based on previous studies[27, 30] and the observation of local TCR clone expansion (Figure 7B,E), the expression of ITGAE/ENTPD1 was considered to serve as a general marker for tumor‐reactiveness also for these CD4+/CD8+ T cells (Figure 7C,F). The gene discussed is CD4; the disease is neoplasm.